Cytokines and Helicobacter pylori - A growth area by Playford, R
Cytokines and Helicobacter pylori - A growth area
Playford, R
 
 
 
 
 
 
 
For additional information about this publication click this link.
https://qmro.qmul.ac.uk/jspui/handle/123456789/220
 
 
 
Information about this research object was correct at the time of download; we occasionally
make corrections to records, please therefore check the published record when citing. For
more information contact scholarlycommunications@qmul.ac.uk
doi:10.1136/gut.39.6.881 
 1996;39;881-882 Gut
  
R Playford 
  
 Cytokines and Helicobacter pylori--a growth area.
 http://gut.bmj.com
Updated information and services can be found at: 
 These include:
 service
Email alerting
the top right corner of the article 
Receive free email alerts when new articles cite this article - sign up in the box at
 Notes   
 http://journals.bmj.com/cgi/reprintform
To order reprints of this article go to: 
 http://journals.bmj.com/subscriptions/
 go to: GutTo subscribe to 
 on 29 July 2008 gut.bmj.comDownloaded from 
Commentary
Cytokines and Helicobacterpylori - a growth area
Yasunaga and coworkers describe their experiments, which
examine the relation between Helicobacter pylori
colonisation, mucosal production of various cytokines and
growth factors, and enlarged fold gastritis. They find that
H pylori colonisation was associated with increased release
of hepatocyte growth factor (HGF) and interleukin 113
(IL1l 1) and that the release of HGF by mucosal biopsy
specimens in vitro was reduced by the addition of an IL1 13
receptor antagonist, suggesting that changes in these two
factors were linked. Samples taken from patients with
enlarged fold gastritis (all were Hpylori+ve) had the highest
amounts of HGF immunoreactivity and HGF and IL1 13
release of all the groups studied. Importantly, after Hpylori
eradication, the size of the enlarged folds reduced in
parallel with reduction in ILl13 and HGF levels, further
supporting the idea that a close link exists between Hpylori
colonisation, cytokine release, growth factor production,
and mucosal growth.
Their paper therefore begins to examine the complex
interrelation between colonisation with H pylori, cytokine
release, growth factor production, and mucosal growth.
Hitherto, individual studies in this area have tended only
to examine the relation between two of these four
variables.
Cytokines and Hpylori colonisation
It is now accepted that there is a close relation between
colonisation with H pylori and the development of chronic
active gastritis and peptic ulceration. The details of how
the presence ofH pylori causes these effects are less clear
but it is probable that cytokine production by the organism
itself or by the patient in respone to the presence of the
organism, is relevant to this process. Several pro-
inflammatory agents have been implicated in these
responses. Those originating from the bacterium itself
include the membrane lipopolysaccharide, urease (which
acts as a chemotactic agent for monocytes and neutrophils
in vitro), vacuolating cytotoxin, and the heat shock
proteins.
The lipopolysaccharides and water soluble surface
proteins of H pylori increase the production of IL13,
tumour necrosis factor (TNF), and the reactive superoxide
anion by activated monocytes/macrophages.1 Tissue levels
of IL8 also appear to be raised in H pylori infected people.
A close link between H pylori colonisation and IL8 and
TNFao levels is supported by the finding that tissue levels
ofmRNA for IL8 and TNFot decrease after eradication of
the organism.2 Interestingly, Gionchetti and coworkers,3
found no significant differences in IL 13 levels between H
pylori+ve and -ve subjects, a result which differs from the
findings presented in this issue.
The main rationale for looking at these relations was that
the presence of increased cytokine concentrations might
well be important in perpetuating the inflammatory
process (by direct toxic effects on the epithelium as well
as recruiting additional inflammatory cells). In addition,
the production of these cytokines might directly stimulate
the G cells to secrete gastrin, thereby explaining the
hypergastrinaemia and increased acid production usually
seen in patients with duodenal ulceration.
Growth factor production andHpylori colonisation
Several early studies reported that peptic ulceration was
associated with decreased epidermal growth factor (EGF)
levels in gastric juice and saliva.4 5 H pylori status was not
examined (although it is reasonable to presume that there
was a high carriage rate of H pylori in these patients). A
recent study in Gut, however, did not find reduced levels
ofEGF in peptic ulcer patients.6
Gastric mucosal EGF immunoreactivity7 and messenger
RNA levels are generally considered to be extremely low
under non-damaged conditions, with the vast majority of
gastric juice EGF being derived from swallowed saliva. It
is important to note however, that this idea has recently
been questioned.6
Transforming growth factor ox (TGFao) is a potent
mitogen and binds to the same receptor as EGF. In
contrast with the low levels of mucosal EGF seen in the
normal stomach, mucosal levels of TGFox are high.7
Studies suggesting that TGFox might play an important
part in controlling growth of the gastric mucosa include the
finding that transgenic animals, which overexpress TGFox
in the gastric mucosa have marked mucosal hyperplasia
resembling Menetrier's disease. Changes in the concen-
tration of TGFot within the mucosa and in gastric juice in
various pathophysiological states are also being examined
by various groups, at present there is no general consensus
regarding whether any consistent changes in TGFox levels
occur. In the paper published in this issue, no difference
in tissue TGFao levels were found between Hpylori+ve and
-ve subjects whereas a preliminary study by Persico et al,
found that H pylori colonisation of the stomach was
associated with reduced mucosal TGFaL tissue concen-
trations.8 Interestingly, Stachura and coworkers found that
continued administration of aspirin to volunteers increased
mucosal TGFox levels, suggesting TGFax might be
important in the adaptive response to noxious agents.9
HGF, also known as scatter factor, binds to the C-met
receptor and is a potent stimulant of proliferation and cell
migration in epithelial cells. Kondo and coworkers have
previously reported that H pylori colonisation is associated
with increased levels of HGF messenger RNA in gastric
mucosa and suggested that this effect was probably
mediated through 'the mucosal inflammation'.10 The
present study by Yasunaga showing that IL 13 antagonists
reduced the production of HGF suggests a much closer
link between cytokine and growth factor production than
was previously recognised. Their findings that HGF levels
were highest in patients with large fold gastritis and that
HGF levels fall in parallel with changes in fold thickness
(after H pylori eradication) also implicates this growth
factor in the trophic response.
H pylori colonisation is undoubtedly important in the
production of gastritis and peptic ulceration. The inflam-
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matory process is probably due to a combination of toxic
pro-inflammatory agents produced directly by the
organism and by the patient's immune system in its efforts
to eradicate the organism. Until recently the major focus
has been on cytokine production in response to this
infection. The finding that IL1 antagonists reduce the
production of the growth factor HGF, however, suggests
that we should pay closer attention to the link between pro-
inflammatory cytokines and growth factor production
including examination of the molecular mechanism(s)
involved. Examination of this area might provide new
insights into why only a small subpopulation of H pylori
colonised subjects go on to develop peptic ulceration and
might also be relevant to the apparent link between Hpylori
colonisation and abnormal mucosal growth in conditions
such as large fold gastritis and gastric carcinoma.
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